Breaking News, Collaborations & Alliances

RedHill Biopharma Ramps-Up Manufacturing of Opaganib

Collaborates with specialty manufacturers in Europe and Canada.

By: Contract Pharma

Contract Pharma Staff

RedHill Biopharma Ltd., a specialty biopharmaceutical company, has announced collaborations with two specialist pharmaceutical manufacturers in Europe and Canada to ramp-up manufacturing of opaganib, currently in global Phase 2/3 and U.S. Phase 2 studies for severe COVID-19 pneumonia, to support potential emergency use applications and subsequent demand.   “In light of the rapid progress of our Phase 2/3 COVID-19 development program with opaganib, we are expanding manufacturing capabilities and ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters